HIV Clinical Trials in Chatsworth, KwaZulu-Natal
2 recruitingChatsworth, KwaZulu-Natal, South Africa
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled27 locationsNCT07071623
Recruiting
Phase 2
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
HIV
National Institute of Allergy and Infectious Diseases (NIAID)200 enrolled21 locationsNCT06812494